Vinyl sulfonates (compounds 19, 20, and 21) (Table 1) have been reported as excellent Nrf2 activators with therapeutic potentials for the treatment of Parkinson’s disease [115]. The gene discussed is NFE2L2; the disease is Parkinson disease.